ATE171212T1 - Corticotropin freisetzende rezeptoren des faktor 2 - Google Patents
Corticotropin freisetzende rezeptoren des faktor 2Info
- Publication number
- ATE171212T1 ATE171212T1 AT95925271T AT95925271T ATE171212T1 AT E171212 T1 ATE171212 T1 AT E171212T1 AT 95925271 T AT95925271 T AT 95925271T AT 95925271 T AT95925271 T AT 95925271T AT E171212 T1 ATE171212 T1 AT E171212T1
- Authority
- AT
- Austria
- Prior art keywords
- receptors
- releasing factor
- corticotropin releasing
- sub
- expressing
- Prior art date
Links
- 101000957708 Catostomus commersonii Corticoliberin-2 Proteins 0.000 title 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25995994A | 1994-06-14 | 1994-06-14 | |
| US08/381,433 US5786203A (en) | 1994-06-14 | 1995-01-31 | Isolated nucleic acid encoding corticotropin-releasing factor2 receptors |
| US48598495A | 1995-06-07 | 1995-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE171212T1 true ATE171212T1 (de) | 1998-10-15 |
Family
ID=27401275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95925271T ATE171212T1 (de) | 1994-06-14 | 1995-06-14 | Corticotropin freisetzende rezeptoren des faktor 2 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6723841B2 (de) |
| EP (1) | EP0724637B2 (de) |
| JP (1) | JPH10501420A (de) |
| AT (1) | ATE171212T1 (de) |
| AU (1) | AU703140B2 (de) |
| CA (1) | CA2193072A1 (de) |
| DE (1) | DE69504808T3 (de) |
| DK (1) | DK0724637T4 (de) |
| ES (1) | ES2123269T5 (de) |
| WO (1) | WO1995034651A2 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030232329A1 (en) * | 1994-06-10 | 2003-12-18 | Jeffrey R. De Wet | Novel human crh receptor-related receptor |
| EP0845035A2 (de) * | 1995-06-13 | 1998-06-03 | The Salk Institute For Biological Studies | Urocortin peptiden |
| US6214797B1 (en) | 1995-06-13 | 2001-04-10 | The Salk Institute For Biological Studies | Urocortin peptides, nucleic acid encoding same methods for using same |
| AU7655596A (en) | 1995-12-06 | 1997-06-27 | Sumitomo Pharmaceuticals Company, Limited | Novel semaphorin z and gene encoding the same |
| JP3961570B2 (ja) * | 1996-02-28 | 2007-08-22 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | 植物プロトポルフィリノーゲンオキシダーゼをコードするdna分子およびその阻害物質耐性突然変異体 |
| US5888811A (en) * | 1996-05-23 | 1999-03-30 | Dupont Pharmaceuticals Company | Corticotropin-releasing hormone receptor |
| AU7935098A (en) * | 1997-06-30 | 1999-01-19 | Taisho Pharmaceutical Co., Ltd. | Proteins capable of binding to corticotropin-releasing factor |
| WO2000063367A1 (en) * | 1999-04-15 | 2000-10-26 | Warner-Lambert Company | A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
| KR20020092891A (ko) * | 1999-07-15 | 2002-12-12 | 리서치 디벨럽먼트 파운데이션 | 코르티코트로핀 분비 인자 수용체 2 결핍 마우스 및 이의용도 |
| US7674463B1 (en) * | 1999-07-15 | 2010-03-09 | Research Development Foundation | Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist |
| WO2001014888A1 (en) * | 1999-08-24 | 2001-03-01 | The Regents Of The University Of California | Method of identifying urotensin ii receptor antagonists |
| AU2001280632A1 (en) * | 2000-07-19 | 2002-01-30 | Bristol-Myers Squibb Pharma Company | CRF2 ligands in combination therapy |
| JP4830079B2 (ja) * | 2000-11-29 | 2011-12-07 | 国立感染症研究所長 | プロテアーゼ活性の測定方法 |
| US6670140B2 (en) | 2001-03-06 | 2003-12-30 | The Procter & Gamble Company | Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| WO2005103690A2 (en) * | 2004-04-24 | 2005-11-03 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2) |
| US8445199B2 (en) * | 2008-12-31 | 2013-05-21 | Abbott Point Of Care Inc. | Method and device for immunoassay using nucleotide conjugates |
| JOP20170153A1 (ar) | 2016-07-15 | 2019-01-30 | Lilly Co Eli | نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030232329A1 (en) | 1994-06-10 | 2003-12-18 | Jeffrey R. De Wet | Novel human crh receptor-related receptor |
| US5786203A (en) | 1994-06-14 | 1998-07-28 | Neurocrine Biosciences, Inc. | Isolated nucleic acid encoding corticotropin-releasing factor2 receptors |
-
1995
- 1995-06-14 AT AT95925271T patent/ATE171212T1/de not_active IP Right Cessation
- 1995-06-14 EP EP95925271A patent/EP0724637B2/de not_active Expired - Lifetime
- 1995-06-14 DE DE69504808T patent/DE69504808T3/de not_active Expired - Lifetime
- 1995-06-14 WO PCT/US1995/007757 patent/WO1995034651A2/en not_active Ceased
- 1995-06-14 AU AU29455/95A patent/AU703140B2/en not_active Ceased
- 1995-06-14 DK DK95925271T patent/DK0724637T4/da active
- 1995-06-14 ES ES95925271T patent/ES2123269T5/es not_active Expired - Lifetime
- 1995-06-14 JP JP8502539A patent/JPH10501420A/ja active Pending
- 1995-06-14 CA CA002193072A patent/CA2193072A1/en not_active Abandoned
-
2001
- 2001-06-13 US US09/881,401 patent/US6723841B2/en not_active Expired - Fee Related
-
2004
- 2004-04-09 US US10/821,502 patent/US7034118B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK0724637T4 (da) | 2002-09-16 |
| US6723841B2 (en) | 2004-04-20 |
| ES2123269T5 (es) | 2002-11-01 |
| WO1995034651A2 (en) | 1995-12-21 |
| EP0724637A1 (de) | 1996-08-07 |
| US20020077468A1 (en) | 2002-06-20 |
| US20040185533A1 (en) | 2004-09-23 |
| WO1995034651A3 (en) | 1996-03-14 |
| DK0724637T3 (da) | 1999-06-14 |
| AU2945595A (en) | 1996-01-05 |
| EP0724637B1 (de) | 1998-09-16 |
| US7034118B2 (en) | 2006-04-25 |
| AU703140B2 (en) | 1999-03-18 |
| DE69504808T2 (de) | 1999-05-12 |
| EP0724637B2 (de) | 2002-06-05 |
| CA2193072A1 (en) | 1995-12-21 |
| DE69504808D1 (de) | 1998-10-22 |
| DE69504808T3 (de) | 2002-12-12 |
| JPH10501420A (ja) | 1998-02-10 |
| ES2123269T3 (es) | 1999-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE171212T1 (de) | Corticotropin freisetzende rezeptoren des faktor 2 | |
| WO1996034107A3 (en) | Antiviral proteins, dna coding sequences therefor, and uses thereof | |
| DE69333731D1 (de) | Glialmitogene faktoren, ihre herstellung und verwendung | |
| BR9814404A (pt) | " clonagem de expressão em fungos filamentosos " | |
| BR9812540A (pt) | Expressão de genes endógenos por recombinaçãonão homóloga de uma construção de vetor comdna celular | |
| EP1005540A4 (de) | Ikk-beta proteines, nukleinsäuren und verfahren | |
| EP0804609A4 (de) | NEUARTIGE AUF p53 ANSPRECHENDE GENE | |
| DE69534300D1 (de) | Neues multimerisierendes reagenz | |
| WO2002086144A3 (en) | Compositions and methods for recombinational cloning of nucleic acid molecules | |
| PL1675956T3 (pl) | Minimalna sekwencja DNA działająca jako insulator chromatyny i jej zastosowanie do wyrażania białek | |
| WO1996015144A3 (en) | Chromosome 21 gene marker, compositions and methods using same | |
| WO1996007739A3 (en) | Interleukin-1 type 3 receptors | |
| WO1996001317A3 (en) | Mammalian peroxisome proliferator-activated receptors and uses thereof | |
| AU5559499A (en) | Identification of the gene causing the mouse scurfy phenotype and its human ortholog | |
| ATE196926T1 (de) | Gen grb3-3, variante und ihre verwendungen | |
| EP0724644A4 (de) | Für die untereinheiten der 1,3-beta-d-glucansynthase kodierende dna | |
| DK0877758T3 (da) | Oprenset SR-p70-protein | |
| WO1999047558A3 (en) | T cell costimulatory proteins, sequences and uses thereof | |
| DK0643719T3 (da) | Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor | |
| DE69619808D1 (de) | Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän | |
| DE69634134D1 (de) | Klonierung von pheromon rezeptoren aus vertebraten und deren verwendungen | |
| SE9602822D0 (sv) | New receptor | |
| AR022150A1 (es) | Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados | |
| ATE281519T1 (de) | Klonierung und rekombinante herstellung des crf- rezeptors (crf=corticotropin ausloese faktor) | |
| ZA982009B (en) | Isolated nucleic acid molecules encoding SSX family members and uses thereof. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |